Segment Information (Details) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
|
Sep. 30, 2019
USD ($)
|
Sep. 30, 2018
USD ($)
|
Sep. 30, 2019
USD ($)
segment
|
Sep. 30, 2018
USD ($)
|
Dec. 31, 2018
USD ($)
|
|
| Segment Reporting Information [Line Items] | |||||
| Number of Reportable Segments | segment | 2 | ||||
| Number of Operating Segments | segment | 3 | ||||
| Net Revenue | $ 9,772 | $ 5,173 | $ 25,499 | $ 17,891 | |
| Loss from operations | (22,540) | (28,205) | (80,438) | (87,775) | |
| Assets | 221,588 | 221,588 | $ 140,993 | ||
| Assets held for sale | $ 13,089 | ||||
| Dermatology Products Sales [Member] | |||||
| Segment Reporting Information [Line Items] | |||||
| Net Revenue | 9,492 | 5,168 | 23,816 | 17,366 | |
| Direct cost of goods | (2,702) | (1,406) | (6,972) | (4,546) | |
| Sales and marketing costs | (4,370) | (2,754) | (12,064) | (8,443) | |
| General and administrative | (669) | (505) | (1,808) | (1,270) | |
| Loss from operations | 1,751 | 503 | 2,972 | 3,107 | |
| Assets | 18,697 | 10,765 | 18,697 | 10,765 | |
| Pharmaceutical and Biotechnology Product Development [Member] | |||||
| Segment Reporting Information [Line Items] | |||||
| Net Revenue | 280 | 5 | 1,683 | 525 | |
| Research and development | (15,271) | (19,788) | (57,705) | (62,332) | |
| General and administrative | (9,300) | (8,925) | (27,388) | (29,075) | |
| Loss from operations | (24,291) | (28,708) | (83,410) | (90,882) | |
| Assets | 202,891 | 157,781 | 202,891 | 157,781 | |
| Consolidated [Member] | |||||
| Segment Reporting Information [Line Items] | |||||
| Net Revenue | 9,772 | 5,173 | 25,499 | 17,891 | |
| Direct cost of goods | (2,702) | (1,406) | (6,972) | (4,546) | |
| Sales and marketing costs | (4,370) | (2,754) | (12,064) | (8,443) | |
| Research and development | (15,271) | (19,788) | (57,705) | (62,332) | |
| General and administrative | (9,969) | (9,430) | (29,196) | (30,345) | |
| Loss from operations | (22,540) | (28,205) | (80,438) | (87,775) | |
| Assets | $ 221,588 | 168,546 | $ 221,588 | 168,546 | |
| Assets held for sale | 56,373 | 56,373 | |||
| Total consolidated | $ 224,919 | $ 224,919 | |||
| X | ||||||||||
- Definition The amount of assets including assets held for sale. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount classified as assets attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. No definition available.
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|